(Q46143952)

19 December 2017

title

Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs (English)

1 reference

19 December 2017

author name string

Tadahiko Kohno

1

1 reference

19 December 2017

Lei-Ting T Tam

2

1 reference

19 December 2017

Seth R Stevens

3

1 reference

19 December 2017

James S Louie

4

1 reference

19 December 2017

publication date

1 May 2007

1 reference

19 December 2017

The journal of investigative dermatology. Symposium proceedings

published in

1 reference

19 December 2017

volume

12

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

5-8

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.jidsymp.5650034

exact match

0 references

cites work

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Differentiating the efficacy of the tumor necrosis factor inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Clinical pharmacokinetics of TNF antagonists: how do they differ?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

The role of non-immune IgG in controlling IgG-mediated effector functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Granulomatous infections due to tumor necrosis factor blockade: correction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Granulomatous infectious diseases associated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

Reactivation of latent granulomatous infections by infliximab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSYMP.5650034

7 January 2021

10.1038/SJ.JIDSYMP.5650034

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017